Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Substituted Aniline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for coronavirus inhibitors. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN101168532B reveals a cost-effective two-step synthesis for N-methylpiperazine substituted aniline, offering significant supply chain advantages for pharmaceutical manufacturing.
Patent CN103012239B enables one-pot synthesis for anticancer intermediates. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115999636A introduces a novel hypervalent halonium salt catalyst for high-purity N-substituted aniline production, offering significant supply chain and cost advantages.
Solve β-halopyrrole synthesis challenges with novel palladium-catalyzed method. Achieve 40-62% yields, broad substrate scope, and safe operation for API manufacturing.